Russell Investments Group
TARO

Russell Investments Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Russell Investments Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-120
Closed -$5.08K – 3644
2024
Q1 		$5.08K Buy
+120
New +$5.05K ﹤0.01% 2940
2022
Q4 		– Sell
-318
Closed -$9K – 2982
2022
Q3 		$9K Hold
318
– – ﹤0.01% 2868
2022
Q2 		$11K Sell
318
-779
-71% -$29.7K ﹤0.01% 2842
2022
Q1 		$47K Sell
1,097
-185
-14% -$8.64K ﹤0.01% 2631
2021
Q4 		$64K Hold
1,282
– – ﹤0.01% 2881
2021
Q3 		$82K Hold
1,282
– – ﹤0.01% 2908
2021
Q2 		$92K Hold
1,282
– – ﹤0.01% 3067
2021
Q1 		$95K Sell
1,282
-2,585
-67% -$196K ﹤0.01% 2982
2020
Q4 		$279K Hold
3,867
– – ﹤0.01% 2653
2020
Q3 		$210K Hold
3,867
– – ﹤0.01% 2762
2020
Q2 		$257K Hold
3,867
– – ﹤0.01% 2627
2020
Q1 		$241K Buy
3,867
+434
+13% +$32.2K ﹤0.01% 2482
2019
Q4 		$303K Sell
3,433
-82
-2% -$6.92K ﹤0.01% 2575
2019
Q3 		$268K Sell
3,515
-44
-1% -$3.57K ﹤0.01% 2503
2019
Q2 		$304K Sell
3,559
-183
-5% -$18.1K ﹤0.01% 2415
2019
Q1 		$400K Buy
3,742
+2,135
+133% +$213K ﹤0.01% 2414
2018
Q4 		$136K Sell
1,607
-23,130
-94% -$2.23M ﹤0.01% 2679
2018
Q3 		$2.43M Buy
24,737
+871
+4% +$94.3K ﹤0.01% 1663
2018
Q2 		$2.76M Sell
23,866
-833
-3% -$91.5K 0.01% 1600
2018
Q1 		$2.44M Sell
24,699
-8,140
-25% -$825K ﹤0.01% 1721
2017
Q4 		$3.44M Buy
32,839
+30,582
+1,355% +$3.36M 0.01% 1537
2017
Q3 		$254K Hold
2,257
– – ﹤0.01% 2623
2017
Q2 		$253K Buy
2,257
+156
+7% +$17.6K ﹤0.01% 2636
2017
Q1 		$245K Hold
2,101
– – ﹤0.01% 2650
2016
Q4 		$220K Buy
+2,101
New +$220K ﹤0.01% 2699

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Russell Investments Group's TARO Position: Q2 2024 in Review

Russell Investments Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 120 shares — an estimated $5.08K sold.

Russell Investments Group first reported a position in TARO in Q4 2016 and held it in 25 quarters. The position peaked at $3.44M in Q4 2017. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Russell Investments Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Russell Investments Group sold 120 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $5.08K.
  • Russell Investments Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 25 quarters.
  • Russell Investments Group's Taro Pharmaceutical Industries Ltd. position peaked at $3.44M in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Russell Investments Group's 13F filing for Q2 2024, filed 8 Aug 2024.